The amount of metabolites in your system increases, overwhelming the detoxification circuit
Gastric pentadecapeptide 15 amino acids CAS 137525-51-0 Not classified as a hazardous substance under CLP regulation
Phase 2 cagrilintide weight-management trial Review of cagrilintide and related safety data ClinicalTrials.gov cagrilintide study listings Cagrilintide side effects are best understood as a pattern: digestive symptoms are common, while dehydration, allergic symptoms, severe abdominal pain, or glucose problems need timely review
Ahmed MR, Basha SH, Gopinath D, Muthusamy R, Jayakumar R
It's about awareness
Additionally, using certain substances can cause changes in mental state, and people with kidney failure may not be able to cleanse these substances from their bodies as well